Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Portola Pharmaceuticals
Biotech
Chutes & Ladders—Boehringer’s Corsico jumps to head dev at GSK
Boehringer’s Corsico jumps to head dev at GSK; Kite’s Polverino takes CSO role at Zymeworks; and Kymera taps former Alnylam executive as CMO.
Conor Hale
Sep 21, 2018 10:00am
Chutes & Ladders—CAR-T player Cellectis poaches Novartis exec
Aug 10, 2018 9:00am
Chutes & Ladders—J&J shakeup leaves Duato with largest portfolio
Jun 29, 2018 8:30am
FDA rejects Portola’s lead candidate, pushing shares down
Aug 18, 2016 9:50am
Following a pivotal failure, Portola lays out its case for betrixaban
May 27, 2016 10:27am
